Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma
Fig 7
Associations between PRDX3 and chemokine regulators.
A: PRDX3 and chemokine genes. B: PRDX3 and chemokine receptor genes. *: P < 0.05; **: P < 0.01; ***: P < 0.001; **** = P < 0.0001.